Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03346447 · ClinicalTrials.gov registry record
Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation
A clinical trial, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 23
- Enrollment target
NCT03346447 is a clinical trial that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 23 participants.
The verdict
NCT03346447 has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This is a single-center, prospective, single-blind pilot study to determine baby wipe formulations on an adult dermatitis model.
Interventions
- OTHER Artificial Fecal Enzyme
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2017-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03346447
The ClinicalTrials.gov registry entry for NCT03346447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly-Clark Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Fecal Enzyme is the first listed.
NCT03346447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03346447 about?
NCT03346447 is a clinical study titled "Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation". This is a single-center, prospective, single-blind pilot study to determine baby wipe formulations on an adult dermatitis model.
What is the current status of trial NCT03346447?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2017-10-09. Estimated completion is 2017-11-13.
What interventions are being tested in trial NCT03346447?
The interventions under investigation include: Artificial Fecal Enzyme (OTHER).
Who is sponsoring clinical trial NCT03346447?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.